腹膜后纤维化中输尿管松解术的当代角色:最后手段还是首选治疗?50例分析
该研究前瞻性分析了2012年1月至2016年1月单中心50例因腹膜后纤维化(RPF)致输尿管梗阻行开放输尿管松解术加网膜包裹术的患者。术后3个月96%(48/50)患者拔除支架,12个月94%(47/50)患者拔除支架。作者认为,对于RPF所致输尿管梗阻且对标准治疗反应不快的患者,应考虑输尿管松解术。
要点
- 术后3个月96%(48/50)患者无需支架,12个月94%(47/50)患者无需支架。
- 总体肾小球滤过率1年变化中位数(IQR)为+6(-4至+22)%(P<0.05)。
- 严重并发症(Clavien III或IV级)发生率为12%。
核心结论
- 作者认为,对于腹膜后纤维化所致输尿管梗阻,由高容量专业团队行当代输尿管松解术可使患者成功摆脱支架或肾造瘘管且不损害肾功能。
- 作者建议,所有因腹膜后纤维化导致输尿管梗阻且对标准治疗反应不快的患者均应考虑输尿管松解术。
研究设计与样本
- 前瞻性分析单中心2012年1月至2016年1月50例接受开放输尿管松解术加网膜包裹术的患者,由腹膜后纤维化多学科团队管理,随访至少1年。
主要发现
- 术后3个月48/50(96%)患者无需支架,12个月47/50(94%)患者无需支架。
- 1年时总体肾小球滤过率变化中位数(IQR)为+6(-4至+22)%(P<0.05)。
- 按指征分组1年肾小球滤过率变化中位数(IQR):支架失败组+25(+5至+27)%(P<0.001);支架症状组+0(-17至+6)%(P=0.834);依赖肾造瘘引流组-10(-19至-2)%(P=0.731);患者选择/预防性组0(0至+8)%(P=0.5)。
- 11/50(22%)患者接受额外手术:肾切除术7例、输尿管输尿管吻合术1例、动脉瘤修复1例、Boari瓣1例、输尿管再植入1例。
- 严重并发症(Clavien III或IV级)发生于12%的患者;失血量中位数(IQR)为390(20-1200)mL,住院时间中位数(IQR)为8(3-21)天。
关键数值与推荐
- 手术指征:依赖肾造瘘引流(n=5);支架失败表现为持续性肾积水(n=20);严重支架症状(n=22);患者选择/预防性(n=3)。
临床怎么用
- 作者建议,对于腹膜后纤维化所致输尿管梗阻且对标准治疗反应不快的患者,应考虑输尿管松解术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the outcomes of open ureterolysis in a contemporary cohort of patients presenting with ureteric obstruction secondary to retroperitoneal fibrosis (RPF). PATIENTS AND METHODS: We conducted a prospective analysis of 50 patients undergoing open ureterolysis and omental wrap between January 2012 and January 2016 in a single centre, managed by a multi-disciplinary RPF team. Patients had a minimum follow-up of 1 year. Indications were: nephrostomy-dependent drainage (n = 5); stent failure as evidenced by persistent hydronephrosis (n = 20); severe stent symptoms (n = 22); and patient choice/pre-emptive (n = 3). Outcome measures were stent-free rate; change in renal function post-ureterolysis; operating variables (operating time, blood loss, complications, length of hospital stay); and need for further intervention. RESULTS: Of the 50 patients, 48 (96%) were stent-free at 3 months and 47/50 (94%) were stent-free at 12 months. The median (interquartile range [IQR]) changes in glomerular filtration rate, according to these indication groups, at 1 year were: overall +6 (-4 to +22)% (P < 0.05); stent failure +25 (+5 to +27)% (P < 0.001); stent symptoms +0 (-17 to +6)% (P = 0.834); nephrostomy-dependent drainage -10 (-19 to -2)% (P = 0.731); and pre-emptive 0 (0 to +8)% (P = 0.5). A total of 11/50 patients (22%) underwent additional procedures: nephrectomy, n = 7; uretero-ureterostomy, n = 1; aneurysm repair, n = 1; 1 Boari flap, n = 1; and ureteric re-implant, n = 1. Serious complications (Clavien III or IV) occurred in 12% of patients. The median (IQR) blood loss was 390 (20-1,200) mL and the median (IQR) length of hospital stay was 8 (3-21) days. CONCLUSIONS: This study suggests that for patients with ureteric obstruction caused by RPF, contemporary ureterolysis performed by a high-volume specialist team can successfully render patients stent- or nephrostomy-free without compromising renal function. The results suggest that ureterolysis should be considered in all patients who present with ureteric obstruction caused by RPF that does not respond quickly to standard treatment.
引用
- O'Brien T, Fernando A. Contemporary role of ureterolysis in retroperitoneal fibrosis: treatment of last resort or first intent? An analysis of 50 cases. BJU Int. 2017. PMID: 28502080. doi:10.1111/bju.13915
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。